Join Our Research Study on Gastric Fundal Mucosal Ablation (GFMA) for Weight Management
We are running a study to see how a new weight-loss procedure, called gastric fundal mucosal ablation (GFMA), works for people who have stopped taking weight-loss medications like semaglutide or tirzepatide.
If you meet certain health requirements and are willing to participate, the study will take about 15 months. Participants will receive the GFMA procedure free of cost and will be compensated for their study-related time, effort, and inconvenience with both monetary ad non-monetary compensation, up to $2,550.
The procedure will take place at our clinic in Cary, NC.
Contact us today if you are interested in participating. You may reach us by calling 919-689-5189 or emailing research@trueyouweightloss.com.
How to be considered for this clinical trial?
Who
Patients seeking a GFMA procedure with True You Weight Loss clinics.
Key Inclusion Criteria
To participate, you must meet these requirements:
- Be between 21 and 65 years old.
- Have a body mass index (BMI) of 30–45 (you can calculate this online).
- Have lost at least 10% of your body weight while using semaglutide or tirzepatide.
- Have not regained more than 50% of the weight you lost after stopping semaglutide or tirzepatide.
- Used semaglutide or tirzepatide at a stable dose for at least 12 weeks.
- Recently stopped or are planning to stop using these medications (within 24 weeks before the procedure).
- Do not have diabetes or other significant medical issues.
- Are willing and able to participate in study activities and sign a consent form.
- Have internet access and reliable transportation.
Key Exclusion Criteria
You cannot participate if you meet any of these conditions:
- You have insulin-dependent diabetes or a high likelihood of needing insulin soon.
- You take blood-thinning medications or have bleeding problems.
- You have a history of certain stomach surgeries or conditions.
- You are pregnant or planning to become pregnant during the study.
- You use tobacco or medications known to cause weight loss.
- You have active stomach issues like ulcers or untreated infections.
What
The study evaluates how GFMA affects weight management after stopping semaglutide or tirzepatide.
When
Your participation will last up to 15 months ±30 days, including up to 90 days for initial screening and assessment.
Where
The procedure will take place at True You Weight Loss Clinic in Cary, NC.
Why
This study will help us learn if GFMA can reduce or prevent weight regain after stopping certain weight-loss medications.
How
If you’re interested, call 919-689-5189 or email research@trueyouweightloss.com for more information.
Compensation
Participants will receive the GFMA procedure free of cost and will be compensated for their study-related time, effort, and inconvenience with both monetary ad non-monetary compensation.
